11000 Regency, Parkway, Suite 300,
Cary, North Carolina 27518
MicroMass Communications is a US-based healthcare communications agency specialising in behavioural science and change strategies on behalf of pharmaceutical companies. Behavioural science is the scientific and systematic study of behaviour to explain why people behave in certain ways and how their behaviour can be changed. In healthcare, this can be used to improve outcomes. MicroMass is based in Cary, North Carolina, with more than 100 employees. It uses its unique expertise in health behaviour to change patient and provider behaviour and deliver optimal health outcomes. MicroMass provides services across four areas: patient engagement and support; relationships marketing; precommercial and clinical; and health behaviour and consulting. MicroMass clients include leading pharmaceutical companies worldwide such as GlaxoSmithKline, Sanofi, Merck, Novo Nordisk, Novartis, Gilead and Teva pharmaceuticals.
MicroMass Communications was acquired by UDG Healthcare on September 14, 2017.
Join Mergr to view all 90 acquisitions of consumer services companies in 2017, including 20 acquisitions by private equity firms, and 70 by strategics.
Join Mergr to view this profile - and discover more consumer services acquisitions of companies like MicroMass Communications.
No obligation. Cancel anytime.